Retinal Disease and Macular Degeneration
Clinical research activity is centred on exudative age-related macular degeneration, with particular interest in vision-threatening complications affecting the central retina. The focus includes submacular haemorrhage associated with wet AMD and the preservation of retinal function in advanced macular disease.
- Exudative age-related macular degeneration
- Wet AMD
- Submacular haemorrhage
Work in this area reflects a strong ophthalmic emphasis on conditions that can rapidly impair central vision and require specialist retinal care.
Vitreoretinal Surgery
The sponsor is involved in clinical investigation of vitrectomy and other vitreoretinal procedures for haemorrhagic complications of retinal disease. This includes surgical management approaches directed at improving anatomical and visual outcomes in retinal pathology.
- Vitrectomy
- Vitreoretinal intervention
- Retinal haemorrhage management
These interests place emphasis on operative retina care within ophthalmology.
Retinal Bleeding and Subretinal Therapy
Research activity also covers treatment strategies for subretinal bleeding, including approaches that target blood displacement and retinal recovery. The therapeutic scope extends to local retinal interventions designed for haemorrhage secondary to neovascular AMD.
- Subretinal TPA
- Subretinal haemorrhage
- Neovascular AMD
This area highlights a focused interest in acute retinal complications that require coordinated medical and surgical management.
Intravitreal Treatment and Anti-VEGF Therapy
The sponsor’s trial portfolio includes evaluation of intravitreal anti-VEGF therapy in the context of wet AMD and related haemorrhagic complications. Interest in intravitreal gas treatment and combined retinal approaches suggests a therapeutic focus on preserving vision through targeted ocular intervention.
- Anti-VEGF therapy
- Intravitreal SF6 gas
- Ocular injection-based treatment
These studies sit within advanced ophthalmic care for retinal vascular disease.
